Ethicann Pharma receives FDA Pre-IND Comments on Regulatory Pathways & Executes Agreement with Epilepsy Study Consortium
Ethicann receives FDA Pre-IND Comments confirming 505(b)(2) pathway / strategies Ethicann executes Clinical Advisory agreement with Epilepsy Study Consortium BETHESDA, MARYLAND, UNITED STATES, November 28, 2022 /EINPresswire.com/ -- Ethicann …